The three main therapeutic modalities used in the treatment of vWD are desmopressin acetate (DDVAP), transfusion with plasma concentrates that contain vWF and antifibrinolytic agents in which, DDAVP is the preferred treatment of choice in types 1 and 2A vWD with mild to moderate bleeding problems and for the prophylaxis of patients undergoing surgical procedures.